These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1509525

  • 1. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R, Saatçi U, Bakkaloğlu A, Beşbaş N, Başsoy Y.
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [Abstract] [Full Text] [Related]

  • 2. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia.
    Del Vecchio GC, Nigro A, Giordano P, Schettini F, Altomare M, Pietrapertosa A, De Mattia D.
    Acta Haematol; 2007; 118(3):136-40. PubMed ID: 17804900
    [Abstract] [Full Text] [Related]

  • 3. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM, Valsecchi C, Bottasso B, D'Angelo A, Casati S, Ponticelli C.
    Thromb Haemost; 1986 Feb 28; 55(1):31-3. PubMed ID: 3754658
    [Abstract] [Full Text] [Related]

  • 4. [Study of the protein C-protein S system in glomerulopathies and nephrotic syndrome].
    Rostoker G, Gouault-Heilmann M, Levent M, Lang P, Robeva R, Lagrue G.
    Nouv Rev Fr Hematol (1978); 1986 Feb 28; 28(6):359-63. PubMed ID: 2951650
    [Abstract] [Full Text] [Related]

  • 5. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E, Oliver A, Félez J, Barceló P, Fernandez C, Ballarin JA, Fontcuberta J, Rutllant ML.
    Thromb Haemost; 1988 Oct 31; 60(2):137-40. PubMed ID: 3217913
    [Abstract] [Full Text] [Related]

  • 6. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
    Nadir H, Unver S, Ozel AM, Yazgan Y, Gultepe M, Evrenkaya TR, Demirturk L, Gurbuz AK.
    Ren Fail; 2007 Oct 31; 29(1):73-7. PubMed ID: 17365913
    [Abstract] [Full Text] [Related]

  • 7. Tubular functions in familial Mediterranean fever.
    Akkuş S, Calişkan S, Kasapçopur O.
    Turk J Pediatr; 2002 Oct 31; 44(4):317-20. PubMed ID: 12458807
    [Abstract] [Full Text] [Related]

  • 8. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND, Paule P, Toohey J, Hung E, Alikhani S, Darwish R, Pahl MV.
    Arch Intern Med; 1984 Sep 31; 144(9):1802-3. PubMed ID: 6477000
    [Abstract] [Full Text] [Related]

  • 9. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A.
    Sante; 2004 Sep 31; 14(4):261-6. PubMed ID: 15745878
    [Abstract] [Full Text] [Related]

  • 10. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA, Gündüz Z, Düsünsel R, Poyrazoglu HM, Saraymen R, Elmas B.
    Adv Perit Dial; 1999 Sep 31; 15():273-7. PubMed ID: 10682117
    [Abstract] [Full Text] [Related]

  • 11. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L, Miniello VL, Francioso G, Aceto G, DiBitonto G, Penza R.
    Boll Soc Ital Biol Sper; 1982 Sep 15; 58(17):1093. PubMed ID: 7138678
    [Abstract] [Full Text] [Related]

  • 12. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T, Shalev H, Landau D, Dvilansky A.
    Sangre (Barc); 1996 Apr 15; 41(2):155-7. PubMed ID: 9045358
    [Abstract] [Full Text] [Related]

  • 13. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH, Gouault-Heilmann M, Levent M, Bernard D, Ruszniewski P, Lagrue G.
    Ann Med Interne (Paris); 1983 Apr 15; 134(8):713-6. PubMed ID: 6666909
    [Abstract] [Full Text] [Related]

  • 14. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A.
    Nephrologie; 1992 Apr 15; 13(4):151-7. PubMed ID: 1407255
    [Abstract] [Full Text] [Related]

  • 15. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C, Holler E, Göhring P, Poley S, Kolb HJ, Pihusch R, Reinhardt B, Krämling HJ, Haller M, Hiller E.
    Eur J Med Res; 1996 Nov 25; 1(12):571-4. PubMed ID: 9438165
    [Abstract] [Full Text] [Related]

  • 16. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
    Kiraz S, Ertenli I, Oztürk MA, Haznedaroglu IC, Calgüneri M, Atalar E, Ozbalkan Z, Kirazli S, Celik I.
    J Rheumatol; 2003 Feb 25; 30(2):313-5. PubMed ID: 12563687
    [Abstract] [Full Text] [Related]

  • 17. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].
    Højberg AS, Mertz H.
    Ugeskr Laeger; 1995 Jul 10; 157(28):4035-7. PubMed ID: 7645081
    [Abstract] [Full Text] [Related]

  • 18. Protein C and antithrombin III in children with acute leukemia.
    Atlihan F, Karakaş Z, Batun S.
    Turk J Pediatr; 1993 Jul 10; 35(1):45-51. PubMed ID: 8236517
    [Abstract] [Full Text] [Related]

  • 19. High levels of plasma protein C in nephrotic syndrome.
    Pabinger-Fasching I, Lechner K, Niessner H, Schmidt P, Balzar E, Mannhalter C.
    Thromb Haemost; 1985 Feb 18; 53(1):5-7. PubMed ID: 3838827
    [Abstract] [Full Text] [Related]

  • 20. Amyloidosis in children with familial Mediterranean fever.
    Koçak H, Beşbaş N, Saatçi U, Bakkaloğlu A.
    Turk J Pediatr; 1989 Feb 18; 31(4):281-7. PubMed ID: 2486428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.